[go: up one dir, main page]

DK0574782T3 - Dobbeltanalyt-immunassay - Google Patents

Dobbeltanalyt-immunassay

Info

Publication number
DK0574782T3
DK0574782T3 DK93109091T DK93109091T DK0574782T3 DK 0574782 T3 DK0574782 T3 DK 0574782T3 DK 93109091 T DK93109091 T DK 93109091T DK 93109091 T DK93109091 T DK 93109091T DK 0574782 T3 DK0574782 T3 DK 0574782T3
Authority
DK
Denmark
Prior art keywords
dobbeltanalyt
immunoassay
dobbeltanalyt immunoassay
Prior art date
Application number
DK93109091T
Other languages
English (en)
Inventor
Kathy Palmer Ordonez
Salvatore Joseph Salamone
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0574782T3 publication Critical patent/DK0574782T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK93109091T 1992-06-16 1993-06-07 Dobbeltanalyt-immunassay DK0574782T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89919692A 1992-06-16 1992-06-16

Publications (1)

Publication Number Publication Date
DK0574782T3 true DK0574782T3 (da) 1999-06-28

Family

ID=25410609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93109091T DK0574782T3 (da) 1992-06-16 1993-06-07 Dobbeltanalyt-immunassay

Country Status (7)

Country Link
US (1) US5501987A (da)
EP (1) EP0574782B1 (da)
JP (1) JP2726793B2 (da)
CA (1) CA2096495C (da)
DE (1) DE69321655T2 (da)
DK (1) DK0574782T3 (da)
ES (1) ES2123589T3 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720384A (en) * 1996-06-25 1998-02-24 Wu-Chen; Su-Hsiang Laser record protection folder
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
GB2361473C (en) 2000-03-08 2005-06-28 Microgenics Corp Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
US7202348B2 (en) * 2000-04-20 2007-04-10 The University Of Arkansas For Medical Sciences Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
AU2001255537A1 (en) * 2000-04-20 2001-11-07 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
US6669937B2 (en) * 2000-04-20 2003-12-30 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
US7632929B2 (en) 2000-04-20 2009-12-15 The Board Of Trustees Of The University Of Arkansas Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
US6534325B1 (en) * 2000-06-30 2003-03-18 Roche Diagnostics Corporation Immunoassay for the detection of amphetamines, methamphetamines and methylenedioxy designer amphetamines
EP2080511A3 (en) * 2000-08-22 2009-09-30 Shire LLC Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) * 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US6472228B2 (en) * 2000-12-04 2002-10-29 Lifepoint, Inc. Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples
MXPA03011385A (es) * 2001-06-08 2005-03-07 Vector Tobacco Ltd Modeificacion de los niveles de nicotina y nitrosamina en el tabaco.
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) * 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
EP2319540A1 (en) * 2002-02-22 2011-05-11 Shire LLC Sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US20030170917A1 (en) * 2002-03-01 2003-09-11 Roche Diagnostics Corporation Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
US7560239B2 (en) * 2002-06-04 2009-07-14 Lin-Zhi International Inc. Homogeneous enzyme immunoassay for simultaneous detection of multiple analytes
US20040242848A1 (en) * 2003-04-21 2004-12-02 Owens S. Michael Mouse/human chimeric anti-phencyclidine antibody and uses thereof
WO2005000334A1 (en) * 2003-05-29 2005-01-06 New River Pharmaceuticals, Inc. Abuse resistant amphetamine compounds
ES2392170T3 (es) 2003-07-01 2012-12-05 F. Hoffmann-La Roche Ag Sistema de biosensor de afinidad electroquímica y métodos de utilización
US7060847B2 (en) * 2003-07-18 2006-06-13 Roche Diagnostics Operations, Inc. Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US7115383B2 (en) * 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
US7037669B2 (en) * 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US20060024769A1 (en) * 2004-07-29 2006-02-02 Saladax Biomedical Inc. Taxol immunoassay
US20060024768A1 (en) 2004-07-29 2006-02-02 Saladax Biomedical, Inc. Taxol immunoassay
US7294649B2 (en) * 2004-12-17 2007-11-13 Roche Diagnostics Operatins, Inc. Methamphetamine derivatives and conjugates for immunoassay
US20060177883A1 (en) * 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
US20060216767A1 (en) 2005-03-22 2006-09-28 Saladax Biomedical Inc. Docetaxel immunoassay
JP4896959B2 (ja) 2005-03-30 2012-03-14 サラダックス バイオメディカル インク． ドキソルビシン免疫測定法
ES2415655T3 (es) 2006-06-15 2013-07-26 The Board Of Trustees Of The University Of Arkansas Anticuerpos monoclonales que reconocen selectivamente Metanfetamina y compuestos similares a Metanfetamina
WO2008131216A1 (en) 2007-04-20 2008-10-30 The Board Of Trustees Of The University Of Arkansas Hapten compounds and compositions and uses thereof
US9927435B2 (en) * 2009-10-15 2018-03-27 Robert Bosch Gmbh Multisite biosensor and associated method
US11275084B2 (en) * 2010-01-15 2022-03-15 Stanford University Successive sampling device and associated method
US8426143B2 (en) 2011-05-24 2013-04-23 Saladax Biomedical Inc. Gemcitabine immunoassay
US9023353B2 (en) 2013-03-13 2015-05-05 The Board Of Trustees Of The University Of Arkansas Anti-(+)—methamphetamine monoclonal antibodies
CN112649610A (zh) * 2020-12-09 2021-04-13 厦门海洋职业技术学院 一种毛发中甲基苯丙胺类毒品的检测试剂盒及检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays
US4329281A (en) * 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
IE54109B1 (en) * 1982-02-10 1989-06-21 Boots Celltech Diagnostics Assay
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US4868132A (en) * 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US5135863A (en) * 1988-12-23 1992-08-04 Syntex (U.S.A.) Inc. Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
US5028535A (en) * 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
EP0386644B1 (en) * 1989-03-10 1997-06-04 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Reagents for the determination of drugs
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
EP0473065A3 (en) * 1990-08-29 1992-08-26 Abbott Laboratories Simultaneous assay for detecting two or more analytes
AU1911592A (en) * 1991-04-10 1992-11-17 Biosite Diagnostics Incorporated Novel conjugates and assays for simultaneous detection of multiple ligands

Also Published As

Publication number Publication date
EP0574782A2 (en) 1993-12-22
US5501987A (en) 1996-03-26
CA2096495A1 (en) 1993-12-17
JP2726793B2 (ja) 1998-03-11
JPH0694711A (ja) 1994-04-08
DE69321655T2 (de) 1999-05-06
EP0574782B1 (en) 1998-10-21
CA2096495C (en) 2002-07-09
ES2123589T3 (es) 1999-01-16
EP0574782A3 (da) 1994-02-09
DE69321655D1 (de) 1998-11-26

Similar Documents

Publication Publication Date Title
DK0574782T3 (da) Dobbeltanalyt-immunassay
DK145493D0 (da) Antistof
FI381U1 (fi) Oevervaknings- och alarmanordning foer rumsutrymmen
BR9404967A (pt) Imunoensaio
FI931089A0 (fi) Substituerade fenylaettikssyraamider
NO934380D0 (no) Hurtigb}t
NO930523D0 (no) Skrukork
FI510U1 (fi) Rengoeringskort
FI932116L (fi) Nytt hoegtemperatur-dehydreringsfoerfarande
DK117592D0 (da) Osteanlaeg
DK83692D0 (da) Forbindelser
SE9301427D0 (sv) Laasbart laasvred
FI626U1 (fi) Expansionskaerl foer nivaoskillnadsmaetare
FI201U1 (fi) Skidspaorsunderhaollsmaskin
KR940017158U (ko) 기타
FI183U1 (fi) Roeklaoda
FI341U1 (fi) Pelarsko
FI157U1 (fi) Presenning
FI180U1 (fi) Kartongfoerpackning
FI182U1 (fi) Faestdon
FI1186U1 (fi) Trailerbock
FI1U1 (fi) Moebel
FI637U1 (fi) Bettanordning foer en fanersvarv
FI20U1 (fi) Justerbar roerkroek
FI237U1 (fi) Sopram